content_image/510767.jpg content_image/510766.jpg
<img src='content_image/510767.jpg'>

<img src='content_image/510766.jpg'>

will cover a set of activities with operational SMART objectives that must be defined by PERA partners. 

The following non-exhaustive list of potentially interrelated working areas  is proposed for PERA: 

- Formulating ERA issues/problems and (specific) protection goals holistically to address overall system impacts 6 ; 

- Assessing environmental risks resulting from exposure to regulated substances/compounds or products at relevant levels of biological organisation (individual, population, community, ecosystem) and spatio-temporal scales 7 ; 

- Assessing cumulative environmental effects resulting from exposure to multiple regulated substances/compounds or products, and stressors 8 ; 

- Developing and designing tools and methods (including post-market environmental monitoring) for evaluating the e fficiency of risk mitigation measures; 

- M onitoring regulated substances/compounds, or products in different environmental compartments and matrices, and along the food/feed chain 9 ; 

- Integrating of pre- and post-registration data of regulated substances/compounds or products, and other environmental monitoring, surveillance and pesticide/pharmacovigilance data 10 ; 

- Comparing environmental risks of regulated substances/compounds or products with a range of alternative solutions; 

- Developing more coherent, harmonised and interoperable regulatory ERA approaches; 

- Developing a common currency for the assessment of environmental impacts; 

- Integrating regulatory ERAs in EU environmental impact and sustainability assessments, or policy assessments performed by relevant partners in the context of other regulatory frameworks/policies; 

- Developing and implementing the safe and sustainable by design concepts for regulatory ERA 11 ; 

- Identifying areas where revised or new guidelines are needed for the ERA of future/new candidate (innovative, greener) regulated substances/compounds or products; 

- Assessing groups/classes of chemical products for authorisation renewal based on the type of active substance, mode of action, and/or use; 

- Implementing the FAIR (findability, accessibility, interoperability, and reuse) principles for digital ERA data; 

